The Paxman Scalp Cooling System

The Paxman Scalp Cooling System provides the leading scalp-cooling technology for preventing chemotherapy-induced alopecia

The PSCS

The system consists of a compact refrigeration unit, containing a coolant that is circulated through specially designed cooling caps.

Features:

  • Available in 2 models to allow either 1 patient to be treated or 2 patients to be independently treated at the same time.
  • Small, compact size, which is easily manoeuvred (Height 25.2”/64cm (inc. extended support arm 64.9”/165cm) x Width 12.6”/32cm x Depth 16.5”/42cm)
  • Easy-to-read, touch-screen visual display with system-status graphics
  • One-touch switch operation for simple ease of use
  • Scientifically developed, low-temperature, non-viscous coolant with ultra-efficient heat transfer properties
  • Instant cooling capability once connected to the system to allow for immediate use
  • Visual and audible information signals for restricted and no-flow coolant conditions
  • Pay-for-use tokens available in some countries

The Paxman Cooling Caps

The personal, lightweight single-patient-use cold cap is manufactured from medical-grade, soft-silicone material designed to provide a close fit around the patient’s head.

Features:

  • After extensive anthropometric research regarding head shapes, 6 different cap sizes were developed to best meet the needs of all patients
  • Coolant passes through the cap to extract heat from the patient’s scalp
  • Inline temperature sensors ensure the cap maintains an even and consistent temperature at the scalp
  • Neoprene cover insulates and protects from high room temperatures, whilst absorbing condensation
  • Bungee-cord adjustments ensure a close fit to the patient’s scalp
  • Attached to the Scalp Cooling System with quick-release, non-drip plastic couplings
  • Available in both reusable and single-patient-use options depending on the market
MDL No. 86975
© Paxman Coolers 2022
Paxman Locations
Changing the face of cancer around the world
Europe
Austria
Belgium
Bulgaria
Cyprus
Czech Republic
France >
Georgia
Germany
Greece
Hungary
Italy
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Republic of Ireland
Romania
Russian Federation
Serbia
Slovakia
Slovenia
Spain
Sweden
Switzerland
Turkey
Ukraine
Asia
Armenia
Bangladesh
Hong Kong
India
Indonesia
Japan
Malaysia
Pakistan
Singapore
South Korea
North & South Amercia
Argentina
Brazil
Iraq
Colombia
Dominican Republic
Mexico
Puerto Rico
Uruguay
US Virgin Islands
Venezuela
Middle East
Bahrain
Iran
Iraq
Israel
Jordan
Kuwait
Lebanon
Qatar
Saudi Arabia
United Arab Emirates
Africa
Morocco
South Africa
Oceania
Australia
New Zealand